NCT06241807
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
Clinical trial condition
Neoadjuvant Therapy
Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.
119 public trials
45 recruiting studies
Neoadjuvant Therapy trial results
NCT06102395
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
- Locations
-
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
NCT04743102
- Conditions
- Colorectal Neoplasms, Complete Remission, Digestive System Diseases, +19 more
- Locations
-
- Beijing Chaoyang Hospital Beijing, Beijing Municipality, China
NCT04486495
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
- Northwest Clinics Alkmaar, Netherlands
- The Netherlands Cancer Institute Amsterdam, Netherlands
- Gelre Hospital Apeldoorn, Netherlands
NCT05406999
- Conditions
- High Risk Prostate Cancer, Intense Endocrine Therapy, Locally Advanced Prostate Cancer, +1 more
- Locations
-
- Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University Nanjing, Jiangsu, China
Enrolling by Invitation
Adaptive Neoadjuvant Therapy for Esophageal Cancer
NCT06990178
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +8 more
- Locations
-
- 113 Baohe Road,Longgang District,Shenzhen,China Shenzhen, Guangdong, China
Not Yet Recruiting
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
NCT07720921
- Conditions
- Neoadjuvant Therapy, Urothelial Carcinoma of the Renal Pelvis and Ureter
- Locations
-
- Departmeng of Urology, Peking University First Hospita Beijing, Beijing Municipality, China
Not Yet Recruiting
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
NCT07622706
- Conditions
- EGFR Positive Non-small Cell Lung Cancer, NSCLC, Neoadjuvant Therapy
- Locations
-
Not specified
Not Yet Recruiting
QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer
NCT07617818
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial
NCT07599163
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified